A report from the National Infrastructure Commission has called for further bill hikes and a shake-up of the way the UK's ...
The Private Placement remains subject to the final approval of the Toronto Stock Exchange. All securities issued as part of the Offering are subject to a four‐month and one‐day hold period from the ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...